| In vivo evidence for GDP-fucose transport in the absence of transporter SLC35C1 and putative transporter SLC35C2. | In vivo evidence for GDP-fucose transport in the absence of transporter SLC35C1 and putative transporter SLC35C2.
Lu L, Varshney S, Yuan Y, Wei HX, Tanwar A, Sundaram S, Nauman M, Haltiwanger RS, Stanley P., Free PMC Article | 02/6/2024 |
| Congenital disorders of glycosylation with defective fucosylation. | Congenital disorders of glycosylation with defective fucosylation.
Hüllen A, Falkenstein K, Weigel C, Huidekoper H, Naumann-Bartsch N, Spenger J, Feichtinger RG, Schaefers J, Frenz S, Kotlarz D, Momen T, Khoshnevisan R, Riedhammer KM, Santer R, Herget T, Rennings A, Lefeber DJ, Mayr JA, Thiel C, Wortmann SB. | 02/5/2022 |
| Down-regulation of SLC35C1 induces colon cancer through over-activating Wnt pathway. | Down-regulation of SLC35C1 induces colon cancer through over-activating Wnt pathway.
Deng M, Chen Z, Tan J, Liu H., Free PMC Article | 05/1/2021 |
| two Turkish siblings with a novel mutation in GDP-fucose transporter and features of congenital disorder of glycosylation IIc | A novel mutation in leukocyte adhesion deficiency type II/CDGIIc.
Cagdas D, Yilmaz M, Kandemir N, Tezcan I, Etzioni A, Sanal Ö. | 02/13/2016 |
| Fx enzyme and GDP-L-Fuc Tr overexpression in the tumur tissue of colorectal cancer (CRC) patients suggests that GDP-L-Fuc transport to the Golgi apparatus may be an important factor associated with increased alpha(1,6)fucosylation in CRC. | FX enzyme and GDP-L-Fuc transporter expression in colorectal cancer.
Villar-Portela S, Muinelo-Romay L, Cuevas E, Gil-Martín E, Fernández-Briera A. | 03/8/2014 |
| In the rare LAD-II disease, the fucosylation of selectin ligands is disturbed, caused by mutations in SLC35C1, the gene that encodes a GDP-fucose transporter of the Golgi system. (Review) | Hematologically important mutations: leukocyte adhesion deficiency (first update).
van de Vijver E, Maddalena A, Sanal Ö, Holland SM, Uzel G, Madkaikar M, de Boer M, van Leeuwen K, Köker MY, Parvaneh N, Fischer A, Law SK, Klein N, Tezcan FI, Unal E, Patiroglu T, Belohradsky BH, Schwartz K, Somech R, Kuijpers TW, Roos D., Free PMC Article | 09/15/2012 |
| the conserved glycine residues at positions 180 and 277 of SLC35C1 have significant impacts on lectin binding | Identification of functional elements of the GDP-fucose transporter SLC35C1 using a novel Chinese hamster ovary mutant.
Zhang P, Haryadi R, Chan KF, Teo G, Goh J, Pereira NA, Feng H, Song Z. | 09/15/2012 |
| the upregulation of GDP-Fuc Tr plays a pivotal role in increased fucosylation in hepatocellular carcinoma | A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation.
Moriwaki K, Noda K, Nakagawa T, Asahi M, Yoshihara H, Taniguchi N, Hayashi N, Miyoshi E. | 01/21/2010 |
| In the GDP-fucose transporter a new single nucleotide deletion produced an open-reading frame shift & polypeptide truncation. Overexpression of the mutant protein in fibroblasts did not rescue fucosylation. The deletion ablated transporter activity. | Insights into leukocyte adhesion deficiency type 2 from a novel mutation in the GDP-fucose transporter gene.
Hidalgo A, Ma S, Peired AJ, Weiss LA, Cunningham-Rundles C, Frenette PS. | 01/21/2010 |
| Leukocyte adhesion deficiency II patients display dual defect in functoin ang Golgi expression of FUCT1. | Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter.
Helmus Y, Denecke J, Yakubenia S, Robinson P, Lühn K, Watson DL, McGrogan PJ, Vestweber D, Marquardt T, Wild MK. | 01/21/2010 |